Updated:
VERTEX PHARMACEUTICALS INC / MA
Vertex develops and commercializes medicines for cystic fibrosis, blood disorders and acute pain, alongside a pipeline of treatments for other diseases.
Overview
Vertex Pharmaceuticals Incorporated develops and commercializes medicines for serious diseases. Its approved product portfolio addresses cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain. Separate clinical and research programs target additional diseases, including kidney disorders, neuropathic pain and type 1 diabetes. Vertex entered an agreement to acquire Crinetics Pharmaceuticals on July 6, 2026. The acquisition remained subject to closing conditions in its report for the quarter ended June 30, 2026. For fiscal 2025, ended December 31, 2025, the company originally reported USD 12,001.3 million in revenue and net income of USD 3,953.2 million.
Company overview
- Legal name
- VERTEX PHARMACEUTICALS INC / MA
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Boston, MA, United States
- Incorporated in
- MA
- Fiscal year end
- December 31
- SEC CIK
- 0000875320
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $12.0B | $4.0B | $25.6B | $5.1B | $3.6B | |
| FY2024USD | $11.0B | -$535.6M | $22.5B | $4.6B | -$492.6M | |
| FY2023USD | $9.9B | $3.6B | $22.7B | $10.4B | $3.5B | |
| FY2022USD | $8.9B | $3.3B | $18.2B | $10.5B | $4.1B |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research VERTEX PHARMACEUTICALS INC / MA in Altss
Track this company’s investors, transactions and relationships in Altss.